基本信息
浏览量:1
职业迁徙
个人简介
Biography
Iam an Associate Professor of Medicine, in the clinician-educator track and Director of the HIV Clinical Trials program of the Yale AIDS Program, Section of Infectious Diseases of the Yale School of Medicine.
My clinical responsibilities include educating and training medical students, residents and infectious diseases fellows in various capacities in inpatient and outpatient settings; and through structured course work and other teaching sessions. As a faculty of the HIV training track of the Yale-Internal Medicine primary care program and for over 6 years as a faculty of the Human Resources for Health program in Rwanda, I have extensive experience with curriculum development, structuring of residency training programs, and mentoring residents and faculty. In Rwanda specifically, I have and continue to mentor medical residents and junior faculty in quality improvement and clinical research projects that are locally relevant and addressing important infectious diseases-related problems (particularly HIV/AIDS and antimicrobial resistance).
Furthermore, I have facilitated meaningful educational and research collaborations between faculty and trainees across institutions. As the program director of World Bank and HRSA-funded efforts supporting the Liberia College of Physicians and surgeons (LCPS)–run Internal medicine residency training program, I have overseen the selection and deployment of faculty to Liberia, and am responsible for educational programs and activities aimed at strengthening the residency training program. Overall, my expertise and collective experiences to date have positioned me to design and run successful projects around capacity building in low-resource settings including developing and implementing innovative and robust medical training and research programs for faculty, fellows, residents and students.
For 5 years now, I have been the Director of the Yale AIDS Program HIV clinical trials program, and a principal investigator on numerous pharmacokinetic, phase 2 and 3 safety and efficacy trials of novel antiviral compounds (HIV). More, recently, given the alarming rate of new infections among men who have sex with men (MSM), I have focused on HIV prevention trials including being a co-principal investigator on a Yale CIRA funded project, which has supported the formation of a cohort of men who have sex with men, who are at high risk for HIV and are engaged in HIV PrEP services in order to study the impact of substance use on retention in care and adherence to PrEP. I am also a lead investigator on the international DISCOVER trial evaluating TAF/FTC vs TDF/FTC for HIV prevention among MSM and transgender women.
In response to the COVID pandemic, I am Yale principal investigator on multiple investigational therapeutic and preventative clinical trials for COVID-19 including remdesivir (now FDA approved), leronlimab and remdesivir and tocilizumab combination therapy as well as the Pfizer/BioNTech and GSK/Sanofi COVID-19 Vaccine trials.
Iam an Associate Professor of Medicine, in the clinician-educator track and Director of the HIV Clinical Trials program of the Yale AIDS Program, Section of Infectious Diseases of the Yale School of Medicine.
My clinical responsibilities include educating and training medical students, residents and infectious diseases fellows in various capacities in inpatient and outpatient settings; and through structured course work and other teaching sessions. As a faculty of the HIV training track of the Yale-Internal Medicine primary care program and for over 6 years as a faculty of the Human Resources for Health program in Rwanda, I have extensive experience with curriculum development, structuring of residency training programs, and mentoring residents and faculty. In Rwanda specifically, I have and continue to mentor medical residents and junior faculty in quality improvement and clinical research projects that are locally relevant and addressing important infectious diseases-related problems (particularly HIV/AIDS and antimicrobial resistance).
Furthermore, I have facilitated meaningful educational and research collaborations between faculty and trainees across institutions. As the program director of World Bank and HRSA-funded efforts supporting the Liberia College of Physicians and surgeons (LCPS)–run Internal medicine residency training program, I have overseen the selection and deployment of faculty to Liberia, and am responsible for educational programs and activities aimed at strengthening the residency training program. Overall, my expertise and collective experiences to date have positioned me to design and run successful projects around capacity building in low-resource settings including developing and implementing innovative and robust medical training and research programs for faculty, fellows, residents and students.
For 5 years now, I have been the Director of the Yale AIDS Program HIV clinical trials program, and a principal investigator on numerous pharmacokinetic, phase 2 and 3 safety and efficacy trials of novel antiviral compounds (HIV). More, recently, given the alarming rate of new infections among men who have sex with men (MSM), I have focused on HIV prevention trials including being a co-principal investigator on a Yale CIRA funded project, which has supported the formation of a cohort of men who have sex with men, who are at high risk for HIV and are engaged in HIV PrEP services in order to study the impact of substance use on retention in care and adherence to PrEP. I am also a lead investigator on the international DISCOVER trial evaluating TAF/FTC vs TDF/FTC for HIV prevention among MSM and transgender women.
In response to the COVID pandemic, I am Yale principal investigator on multiple investigational therapeutic and preventative clinical trials for COVID-19 including remdesivir (now FDA approved), leronlimab and remdesivir and tocilizumab combination therapy as well as the Pfizer/BioNTech and GSK/Sanofi COVID-19 Vaccine trials.
研究兴趣
论文共 72 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
BMC infectious diseasesno. 1 (2023): 258-5
Expert opinion on drug metabolism & toxicologyno. 12 (2023): 881-888
Abdulaziz Mohammed, Hanna Idris-Dantata,Tochi Okwor, Paul Tanui,Elijah Paintsil, Patrick Chanda Kabwe,Yewande Alimi,Raji Tajudeen, Wessam Mankoula,Olayinka Stephen Ilesanmi,Muhammad Shakir Balogun,Chikwe Ihekweazu,
GLOBAL HEALTH-SCIENCE AND PRACTICEno. 5 (2023): e2300121-e2300121
Kristina Talbert-Slagle, Ibrahim Ajami, Braden Currey, Rachel Galvao, Jerusalem Hadush, Serene Silin Li, Javaughn T Flowers, Moses Ziah, Desmond Amuh, Mikaela Rabb,Olayinka Stephen Ilesanmi,Nikole Allen,
PLOS global public healthno. 3 (2023): e0001610-e0001610
Elijah Paintsil,Yewande Alimi,Mohammed Abdulaziz,Onyema Ogbuagu,Folasade Ogunsola, Suzan Joseph Kessy, Emilio Horsney,Christopher Lee, Karen Brundney,Tochi Okwor, Patrick Kabwe, Ariyo Waheed,
BMC Public Healthno. 1 (2023): 893-14
Deborah M. Oyeyemi, Elizabeth Chan, Mason Montano,Annika Belzer,Onyema Ogbuagu,Heidi Zapata,Jessica J. Tuan
引用0浏览0WOS引用
0
0
Elijah Paintsil, Yewande Alimi,Mohammed Abdulaziz,Onyema Ogbuagu,Folasade Ogunsola, Suzan Joseph Kessy, Emilio Horsney, Christopher Lee, Karen Brundney,Tochi Okwor, Patrick Kabwe, Ariyo Waheed,
BMC public healthno. 1 (2023): 893-893
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn